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Foot-and-mouth disease virus (FMDV) is one of the most extensively studied animal pathogens
because it remains a major threat to livestock economies worldwide. However, the dynamics of
FMDV infection are still poorly understood. The application of reverse genetics provides the
opportunity to generate molecular tools to further dissect the FMDV life cycle. Here, we have used
reverse genetics to determine the capsid packaging limitations for a selected insertion site in the
FMDV genome. We show that exogenous RNA up to a defined length can be stably introduced
into the FMDV genome, whereas larger insertions are excised by recombination events. This led
us to construct a recombinant FMDV expressing the fluorescent marker protein, termed iLOV.
Characterization of infectious iLOV-FMDV showed the virus has a plaque morphology and rate of
growth similar to the parental virus. In addition, we show that cells infected with iLOV-FMDV are
easily differentiated by flow cytometry using the inherent fluorescence of iLOV and that cells
infected with iLOV-FMDV can be monitored in real-time with fluorescence microscopy. iLOV-
FMDV therefore offers a unique tool to characterize FMDV infection in vitro, and its applications
for in vivo studies are discussed.
INTRODUCTION
Foot-and-mouth disease virus (FMDV) is the aetiological
agent of foot-and-mouth disease (FMD) of cloven-hoofed
animals. FMDV is highly contagious, and outbreaks are a
major threat to global food security due to their devastating
economic effects. FMDV belongs to the genus Aphthovirus
of the family Picornaviridae and has a positive-sense single-
stranded RNA genome encapsidated within a non-
enveloped icosahedral shell. An internal ribosome entry site
facilitates translation of the FMDV genome, yielding a
polyprotein that is subsequently processed to a number of
intermediate products and 12 mature proteins: the non-
structural auto-proteinase (Lpro); the structural proteins
VP4 (1A), VP2 (1B), VP3 (1C) and VP1 (1D) and the
remaining non-structural proteins (nsp) 2A, 2B, 2C, 3A, 3B,
3Cpro and 3Dpol (Forss et al., 1984; Rueckert, 1996). During
translation of the FMDV polyprotein, an intra-ribosomal
self-processing event occurs at the C terminus of 2A
separating the region containing the capsid proteins (P1)
from most of the non-structural proteins. 2A is subsequently
cleaved from P1 at its N-terminal by the 3C protease, which
is responsible for the majority of the remaining proteolytic
cleavages in the FMDV polyprotein.
In 1898, FMDV was the first animal disease shown to be
caused by a virus (Rott & Siddell, 1998). Over a century of
active investigation has led to the elucidation of many
aspects of the FMDV life cycle; however, critical knowledge
about virus–host interactions is still lacking, including the
complete identification of host cell types permissive to
infection and the characterization of viral dissemination
following known routes of natural infection. At present,
identification of the host cell repertoire targeted by FMDV
during infection relies on the use of specific antibodies that
detect viral non-structural proteins in permeabilized cells,
an invasive technique that does not facilitate the visualiza-
tion of these nsp in real-time as an infection progresses.
With this in mind, we decided to initiate the development
of a recombinant FMDV expressing an easily detectable
fluorescent marker that can be used to further characterize
the FMDV life cycle.
The ability to successfully generate a recombinant infectious
picornavirus that expresses a fluorescent marker protein is
dependent on several factors, including the site of insertion
targeted in the viral genome, the size and stability of the
exogenous RNA that is inserted, the packaging limits imposed
by the viral capsid and the expression and detection of the
encoded fluorescent protein. In this study, we used a reverse
genetics approach and the inherent processing events that
occur either side of the 2A product within the FMDV
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polyprotein to produce recombinant FMDVs (rFMDVs)
containing different exogenous RNA insertions. Furthermore,
characterization of these rFMDVs provided insight into capsid
packaging limitations for the selected insertion site, allowing us
to construct, characterize and report for the first time an
infectious fluorescent rFMDV.
RESULTS
GFP-FMDV and Renilla luciferase-FMDV are non-
viable and function as replicons
In order to better study the FMDV life cycle, a reverse
genetics approach was utilized to generate recombinant
infectious copy viruses designed to express either the GFP
of Aequorea victoria or the Renilla luciferase protein (RL)
of Renilla reniformis, as an N-terminal fusion product of
the non-structural FMDV 2A protein (Fig. 1). The genomic
site utilized for insertion of the GFP or RL ORF was
selected in order to retain the auto-catalytic cleavage of the
2A product at its C terminus. This cleavage facilitates the
release of the P1 region from the nascent polyprotein.
Similarly, the 3C protease cleavage site at the C-terminal of
the VP1 capsid protein was retained to facilitate release of
the N terminus of the 2A fusion protein (GFP-2A).
With the intention of generating viral stocks, transcripts
made from the GFP infectious clone were first electro-
porated into BHK-21 cells (passage 0 stock, P0). Whole-cell
lysates prepared from the electroporated cells were then
used to infect goat epithelium cells (P1) expressing the
principal FMDV receptor, integrin avb6 (Jackson et al.,
2000). Three additional passages were performed in the
goat epithelium cells, producing P2 to P4 stocks. During
these consecutive passages, cytopathic effect (CPE) was
only observed in goat epithelium cells infected with the P3
virus stock. In addition, we were unable to detect GFP
expression by Western blot analysis and fluorescence
microscopy (data not shown), in any of the virus stocks.
Picornaviruses including FMDV are notorious for their
recombination abilities; therefore, sequence analysis of the
P4 virus stocks was carried out to check for the presence of
an intact GFP ORF. As expected, the sequence data
revealed a single virus population (at the consensus level)
that had lost the inserted GFP ORF (Fig. 2a). Similarly, we
were unable to generate infectious virus expressing RL
when the encoding ORF was inserted into the same site of
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Fig. 1. Cloning strategy utilized to construct FMDV infectious copy plasmids encoding the Renilla luciferase protein (RL) or
different portions of GFP. (a) Schematic representation of the FMDV genome and encoded protein products. (b) Schematic
representation of the FMDV genome site utilized for the insertion of the RL gene or different portions of the GFP gene. The
retained 3C cleavage site at the C terminus of VP1 and the amino acids (underlined) encoded by the introduced AvrII restriction
endonuclease site used for cloning the insertions are shown. The RL and different GFP insertions are depicted below, along
with their respective nomenclature (T2- to T7-FMDV, GFP-FMDV, RL-FMDV), nt length (in parentheses) and encoded peptide.
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the FMDV genome. Once again, CPE was only observed in
goat epithelium cells infected with the P3 virus stock.
Sequence analysis of the P4 virus stock revealed two virus
subpopulations (at the consensus level) that had lost most,
if not all, of the inserted RL ORF (Fig. 2a). We therefore
investigated the inability of the FMDV genome to retain
the GFP insertion. At first, experiments were carried out to
exclude the possibility of the FMDV genome being unable
to competently replicate in the presence of the GFP
sequence. To do this, BHK-21 cells were transfected with
full-length RNA prepared from the GFP-FMDV infectious
copy plasmid, and a subset was subsequently treated with
guanidine-HCl, a potent inhibitor of FMDV replication
(De Palma et al., 2008; Rott & Siddell, 1998). Fig. 2 (b2e)
shows that in untreated cells GFP-2A is clearly expressed
following transfection; in comparison, no GFP-2A expres-
sion was observed following guanidine-HCl treatment (Fig.
2f). Viral replication was confirmed in the untreated cells
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Fig. 2. GFP and Renilla luciferase (RL) ORF insertions into the FMDV genome are deleted. (a) Sequence analysis of the single
GFP-FMDV and two RL-FMDV deletion variants. The remaining amino acids of each insertion, as well as those flanking each
deletion are shown [see GFP-deleted FMDV and RL-deleted FMDV (1) and (2)]. The amino acids flanking the undeleted
insertions are also shown for reference (see GFP-FMDV and RL-FMDV). (b–f) BHK-21 cells transfected with GFP-FMDV and
treated with the viral replication inhibitor guanidine hydrochloride (+ Gnd-HCl) or left untreated (” Gnd-HCl). GFP-FMDV
replication was clearly visible in the untreated cells as judged by the expression of GFP (green, c) and the non-structural 3A
protein (red, d). In comparison, no obvious replication was observed in the Gnd-HCl-treated cells (f). Nuclei are stained blue
(DAPI). (g) Confirmation by Western blot analysis of GFP-FMDV replication in BHK-21 cells. Whole-cell lysates were analysed
for GFP, the non-structural FMDV 3A protein (and 3A/B precursors, black bar) and c-tubulin (loading control). Asterisks indicate
non-specific bands.
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by immunofluorescence labelling for the non-structural 3A
protein. In addition, Western blot analysis further verified
the expression of the GFP and 3A proteins (Fig. 2g).
Determination of the packaging limitations for the
targeted insertion site
The ability to replicate its genome but not yield infectious
virus suggested the GFP-FMDV was functioning as a
replicon. We therefore decided to investigate whether the
observed inability to generate infectious virus was a result
of exceeding the packaging limitations imposed by the rigid
FMDV capsid. Utilizing the same insertion site within the
FMDV genome, a series of six infectious clones were
constructed that contained increasingly larger portions of
the GFP ORF (T2-FMDV (100 nt), T3-FMDV (200 nt),
T4-FMDV (300 nt), T5-FMDV (400 nt), T6-FMDV
(500 nt) and T7-FMDV (600 nt) (Fig. 1b). In contrast to
the full-length GFP-FMDV, all six truncated GFP-FMDVs
caused CPE in goat epithelium cells infected with the
respective P0 viral stock, indicating the presence of
infectious virus. To confirm the stability of each insertion,
reverse transcriptase PCR (RT-PCR) was performed on
these P1 virus stocks. Fig. 3(b) clearly shows that GFP
portions ¡300 nt in length were retained by their respec-
tive viruses (T2-FMDV, T3-FMDV and T4-FMDV),
whereas portions ¢500 nt were lost (T6-FMDV and T7-
FMDV). Interestingly, RT-PCR carried out on T5-FMDV
indicated the presence of a mixed virus population
consisting of FMDV that had either retained or lost
its 400 nt insert. Sequence analysis (data not shown)
confirmed these results, indicating the maximum size of
RNA that could be inserted into the targeted region of the
FMDV genome, with regard to retaining the insertion over
two passages, was 300–400 nt.
Generation and characterization of an alternative
fluorescent FMDV
The ORFs of full-length GFP (y700 nt) and RL (y800 nt)
both exceed our proposed packaging limit (y400 nt) for
the selected insertion site. Recently, Chapman and collea-
gues engineered a smaller alternative fluorescent protein to
GFP termed iLOV (Chapman et al., 2008). Derived from a
domain of phototropin, a plant blue light receptor, iLOV
has an ORF of y300 nt and encodes a protein of y10 kDa.
We hypothesized that inclusion of the iLOV ORF would fit
the established constraints of the FMDV capsid and decided
to explore the possibility of using the iLOV protein as an
alternative fluorescent medium with which to study the
FMDV life cycle. A codon-optimized version for mam-
malian cell expression of the DNA sequence encoding iLOV
was inserted into the targeted site of the genome to create an
iLOV-FMDV infectious copy virus.
Viral transcripts made from the iLOV-FMDV infectious
clone were electroporated into BHK-21 cells, which were
used to prepare P0 virus stock that was used to infect goat
epithelium cells. Indeed, P0 stocks of iLOV-FMDV were
able to cause CPE in goat epithelial cells. Western blot
analysis using rabbit sera recognizing the iLOV protein
showed expression of a product of the predicted molecular
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Fig. 3. Determination of the packaging limitations for the targeted insertion site of the FMDV genome. (a) Schematic
representation of the FMDV genome, showing the positions of the forward (F) and reverse (R) primers used to investigate the
retention of different portions of the GFP gene. (b) Top: PCR controls performed using the T2- to T7-FMDV infectious copy
plasmids as templates (see Fig. 1b). The PCR products show the expected amplification products derived from each of the
FMDV genomes in the absence of deletions. Bottom: RT-PCR analysis of FMDV genomes (T2- to T7-FMDV) containing
different portions of the GFP gene. FMDV genomes were prepared from goat epithelium cells infected with P0 virus stocks. T6-
and T7-FMDV clearly show deletion of their respective insertions.
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size (Fig. 4a), confirming expression of the encoded N-
terminal iLOV-2A fusion product. In order to confirm
viral replication, expression of the non-structural 3A
protein was also verified by Western blot (Fig. 4a). In
addition, fluorescence microscopy was performed to
corroborate the expression of the iLOV-2A protein in goat
epithelial cells infected with P1 virus stock (Fig. 4b).
Next, we investigated the genetic stability of iLOV-FMDV
in cell culture. Following the initial passage of iLOV-
FMDV in electroporated BHK-21, virus was serially
passaged four more times in goat epithelium cells to yield
P0 to P4 virus stocks. Analysis of the P2, P3 and P4 stocks
by RT-PCR revealed that exogenous iLOV DNA was stably
retained within the FMDV genome over five passages (P0
to P4) (Fig. 4c). Sequence analysis of the entire capsid
region confirmed these results and revealed no mutations
(data not shown). Although our experiments clearly
showed FMDV tolerated the iLOV RNA in terms of both
its packaging capacity and retention, we reasoned that the
insertion of an additional y300 nt into the genome would
decrease the temporal efficiency of replication and possibly
that of encapsidation. We therefore performed growth
comparisons between the parental virus and iLOV-FMDV
(Fig. 4d). As expected, the single-step growth kinetics
exhibited by iLOV-FMDV showed a slightly reduced rate of
growth in goat epithelium cells compared to the parental
virus. To corroborate these results, we infected confluent
monolayers of goat epithelium cells with either the
parental-FMDV or iLOV-FMDV and compared their
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Fig. 4. iLOV-FMDV is viable and stable. (a) Western blot analysis of whole-cell lysates prepared from goat epithelium cells
infected with iLOV-FMDV. Samples were probed for the presence of iLOV, the non-structural FMDV 3A protein (and 3A-B
precursors, black bar) and c-tubulin (loading control). Asterisks indicate non-specific bands. (b) Fluorescence microscopy of
goat epithelium cells infected with iLOV-FMDV. Nuclei are stained blue (DAPI). (c) RT-PCR analysis of iLOV-FMDV genomes
prepared from P2, P3 and P4 virus stocks. Genome derived from the parental wild-type virus was also analysed as a control. (d)
Growth analysis comparison of parental wild-type FMDV and iLOV-FMDV. Goat epithelium cells were infected with the
respective virus (0.1 m.o.i.) and samples analysed at 0, 2, 4, 6 and 8 h post-infection. Similar results were obtained from three
individual experiments. (e) Plaque morphology of goat epithelium cells infected with parental wild-type FMDV or iLOV-FMDV.
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plaque morphologies (Fig. 4e); plaques exhibited similar
morphologies, indicating similar rates of replication.
The above results show iLOV-FMDV replication is not
drastically attenuated in vitro. The construction of a
fluorescent FMDV offers a possible system to detect and
purify infected cells prepared from in vitro and in vivo
studies. With this in mind, we decided to explore
applicable techniques by which iLOV-FMDV replication
can be detected and quantified in cells, including flow
cytometry and live-cell imaging. Fig. 5 shows that we were
able to detect and quantify iLOV-FMDV-infected goat
epithelium cells using flow cytometry; iLov expression was
only detected in cells that were positive for both structural
and non-structural proteins of FMDV. Lower percentages
of iLOV-FMDV-infected cells were detected using anti-
FMDV structural and non-structural antibodies compared
with parental-FMDV-infected cells, which is consistent
with a slightly reduced rate of growth. Live-cell imaging of
iLOV-FMDV-infected goat epithelium cells (Fig. 6 and
Video S1, available in JGV Online) confirmed our initial
fluorescence microscopy observations of fixed cells. iLOV-
2A protein was clearly visible in infected goat cells, which
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Fig. 5. Detection of iLOV-FMDV-infected cells by flow cytometry. Goat epithelium cells were either mock infected or infected with
iLOV-FMDV or parental FMDV at an m.o.i. of 2. After 4 h, cells were analysed by flow cytometry. (a–h) Density plots for iLOV-
FMDV-infected or parental-FMDV-infected cells. (a, b) Infected and unlabelled cells analysed for iLOV expression. (c, d) Infected
cells analysed for iLOV and FMDV non-structural protein 3A expression as detected with mAb 2C2. (e, f) Infected cells analysed
for iLOV and FMDV capsid expression as detected with mAb IB11. (g, h) Infected cells analysed for iLOV expression and labelled
with isotype control mAbs TRT1 and TRT3. (i–l) Histograms displayed for unlabelled cells infected with parental FMDV (i), mock
infected (j), infected with iLOV-FMDV (k) and overlay of parental-FMDV-infected (red) and ILOV-FMDV-infected (black) cells (l).
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exhibited the well characterized phenotype of rounding
and cell death (CPE) in the later stages of infection.
DISCUSSION
The work herein investigates the packaging limitations of
the FMDV capsid for a specific insertion site and explains
why previous attempts to construct FMDV-encoding
fluorescent proteins, such as GFP, failed. In addition, it
provides further evidence that FMDV is able to remove
insertions from its genome that exceed the packaging
limits, possibly by fortuitous recombination events that
maintain the integrity of the encoded viral proteins.
Importantly, we describe for the first time the rescue of
viable FMDV expressing a fluorescent protein, iLOV.
Although not formally established, it is likely that rescue
of the iLOV-expressing virus was successful because the
coding region of this protein is within the limits tolerated
by the virus. The iLOV insertion was genetically stable over
five passages through cell culture. iLOV fluorescence was
readily detected by confocal microscopy and flow cyto-
metry, making it a very useful tool to study FMDV
pathogenesis.
We targeted the junction between P1 and 2A as an
insertion site for exogenous sequences to produce N-
terminal fusion products of the 2A non-structural protein
that were released from the FMDV polyprotein via the
natural processing of 2A and the 3Cpro cleavage site at the
C terminus of the VP1 structural protein. Similar reverse
genetics approaches have been used to investigate the
potential use of poliovirus vectors as vaccines for the
expression of foreign antigens. A number of these viruses
expressed their antigens either (i) as N-terminal additions
to the poliovirus polyprotein or (ii) as an intermediate
product at the junction between precursors P1 and P2
(between the VP1 and 2A products). In both cases,
additional 3Cpro cleavage sites facilitated the release of
product (the antigen) from the polyprotein (Andino et al.,
1994; Mattion et al., 1994, 1995; Mueller & Wimmer, 1998;
Yim et al., 1996). These cloning strategies are particularly
applicable to the arrangement of picornaviral genomes.
Unlike the poliovirus 2A product, which is a bona fide
protease that cleaves its own amino terminus auto-
catalytically, FMDV 2A is processed at its C terminus
during translation of the polyprotein by an autonomous
intra-ribosomal self-processing event.
Initial attempts to generate rFMDVs expressing GFP or RL
were unsuccessful, and all infectious progeny viruses
contained deletions of most, if not all, of their respective
exogenous ORFs. Similar results have been observed in a
study with poliovirus, in which the insertion of the GFP
ORF severely impaired viral replication and was deleted in
the course of serial passage in cell culture (Mueller &
Wimmer, 1998). Unlike this study, although we observed
the replication-dependent expression of GFP-2A in cells
transfected with GFP-FMDV transcripts, we were unable to
generate any GFP-expressing infectious viruses. These
results show the insertion of the GFP ORF into the
FMDV genome imposed replicon-like characteristics.
Replicons bypass cell entry and capsid uncoating, enabling
the analysis of interactions to focus solely on the early
events of viral replication. The use of GFP-FMDV and RL-
FMDV as replicons that encode the complete repertoire of
viral proteins is currently being investigated.
The reasons for the discrepancy between poliovirus and
FMDV with respect to the ability to generate infectious
GFP-expressing virus may involve the different sites of the
genome targeted for insertion, as well as differences in the
capsid packaging limits of the two viruses and the lengths
of their genomes. Compared to the poliovirus genome
(y7.5 kb), the FMDV genome is larger (y8.2 kb), and the
difference is comparable in size to the GFP ORF
(y700 nt). Deletion variants that had lost their GFP or
RL ORF insertion were only observed, as judged by CPE,
after five consecutive passages. In addition, sequence
analysis revealed the presence of only a few deletion
(a)
FMDV iLOV-FMDV Uninfected
(b) (c)
Fig. 6. Detection of iLOV-FMDV-infected cells by live-cell imaging. (a–c) Still images from live-cell imaging experiments during
which goat epithelium cells were infected at an m.o.i. of 2 with either parental-FMDV (a) or iLOV-FMDV (b) or mock infected (c).
Cells imaged by differential interference contrast optics are shown. iLOV-expressing cells (green) are clearly visible in (b). Bar,
20 mm.
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variants; one in the case of GFP, and two for RL. This
suggests that the generation of stable variants was a rare
occurrence; however, the mechanism by which they were
generated is unknown. All three of the deleted viruses
exhibited almost precise deletion of their respective insert;
however, it is likely that the packaging limits per se were
not the only driving force for such complete excision.
Mueller & Wimmer (1998) observed similar deletion
events leading to the loss of foreign sequences that had
been inserted into the poliovirus genome and proposed
two models of illegitimate (non-homologous) recombina-
tion as possible mechanisms. Both models are based on the
presence of short direct sequence repeats in the immediate
vicinity of the deletion borders. In our study, short direct
sequence repeats were present on either side of the
sequences inserted into the FMDV genome in the form
of AvrII restriction sites (CCTAGG), but sequence analysis
of the deletion borders could not confirm a role for these
sites in the recombination events. Numerous reports have
detailed the ability of picornaviruses to generate extensive
genetic variation, due to the unedited mis-incorporation of
nts during RNA synthesis, recombination and other
genomic rearrangements (Agol, 1997; Lukashev, 2010;
Savolainen-Kopra & Blomqvist, 2010), and it is possible
that more than one mechanism of loss was responsible for
the generation of the stable variants. It is also possible that
the codon usage bias in FMDV may influence the excision
process (Zhou et al., 2013).
In order to determine the size of exogenous RNA that
could be stably inserted into the FMDV genome using the
selected target site between P1 and 2A, we constructed a
series of rFMDVs each containing an increasingly larger
portion of the GFP ORF. Our experiments show that
insertions up to 400 nt in length are more stable. These
results are in agreement with poliovirus studies, which
showed recombinant viruses based on polyprotein fusion
or dicistronic expression are more stable if the foreign ORF
is ,400 nt (Lu et al., 1995; Mattion et al., 1994, 1995;
Mueller & Wimmer, 1998; Yim et al., 1996).
It is feasible to suggest that the constraints of the capsid
prevented the GFP-FMDV genome from being packaged.
Nevertheless, a number of factors other than the physical
ability to package have been shown to influence the stability
of foreign ORFs within the poliovirus genome, including
replication competence, the presence of signal sequences or
fortuitous RNA structures and the processing of introduced
cleavage sites (Lu et al., 1995; Lu & Wimmer, 1996; Mattion
et al., 1994, 1995; Yim et al., 1996).
The b-barrel structure of GFP is essential to its function,
inhibiting the production of smaller derivatives that could
be more easily accommodated by the FMDV capsid (Cubitt
et al., 1995; Ormo¨ et al., 1996; Tsien, 1998; Yang et al.,
1996). We therefore decided to investigate the use of iLOV
(Chapman et al., 2008) as an alternative marker for FMDV
replication. iLOV was created from the LOV2 domain
(amino acids 387–496) of the phototropin 2 (phot2) plant
blue light receptor of Arabidopsis thaliana by Chapman
et al. (2008) using molecular evolution and tobacco
mosaic virus (TMV)-based expression screening techni-
ques. Chapman and co-workers also optimized iLOV
codon usage for expression in mammalian cells, dem-
onstrating that iLOV fluorescence can be detected in
human embryonic kidney (HEK) cells (Chapman et al.,
2008). GFP-based fluorescent proteins are inherently
fluorescent; in contrast, iLOV fluorescence relies on its
chromophore co-factor, flavin mononucleotide (FMN).
iLOV expression in goat epithelium cells was confirmed by
confocal microscopy, flow cytometry and live-cell imaging
microscopy, showing that dependency on the cellular co-
factor FMN did not impede detection of its fluorescence.
Furthermore, we did not observe an improvement in
fluorescence as judged by live-cell imaging on addition of
riboflavin to the media of cells infected with iLOV-FMDV
(data not shown). iLOV may exhibit a number of advan-
tages over GFP-based fluorescent proteins. Techniques
such as live-cell imaging utilize recurrent laser scanning,
which exposes fluorescent marker proteins to high light
intensities. This can cause irreversible bleaching of GFP;
however, iLOV has been shown to have a latent
photochemistry that recovers spontaneously. In agreement,
we observed no obvious reduction of fluorescence of iLOV
in our live-cell imaging experiments. The GFP fluorophore
can take a period of hours to mature, hindering real-time
studies investigating the early events of viral life cycles
(Cubitt et al., 1995; Wright et al., 2007). Following the
direct addition of virus to cell media, we commonly
observed iLOV expression after 2 h. Taking into account
the time required for the virus to enter the cell, uncoat and
produce positive-strand templates, these results show that
the initial detection of iLOV coincides with that of the
non-structural proteins (Garcı´a-Briones et al., 2006) and
confirm that iLOV is a feasible alternative for investigating
early viral events.
The smaller size of iLOV compared to GFP may also
alleviate problems associated with dysfunctional GFP
fusions. In this study, iLOV was expressed as an N-
terminal fusion of FMDV 2A. Although FMDV 2A is only
18 amino acids long it may have an additional, as yet
unreported, role other than being involved in processing
the viral polyprotein. The non-structural proteins of RNA
viruses are often pleiotropic, having multifunctional roles
to compensate for the small coding capacity of their
genomes. iLOV-FMDV exhibited a similar rate of replica-
tion and plaque morphology to the parental virus,
suggesting that if the 2A product has additional functions
these were not impeded. In addition, we have constructed a
variant infectious rFMDV (termed iLOV-3C-FMDV) in
which a 3C cleavage site was introduced at the C terminus
of iLOV in order to generate separate iLOV and 2A
products. The spatial and temporal expression of iLOV
protein was comparable, as judged by live-cell imaging, in
goat epithelium cells infected with iLOV-FMDV or iLOV-
3C-FMDV (data not shown).
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Although iLOV fluorescence was recoverable in compar-
ison to other GFP constructs or fluorophores routinely
used by our group, the fluorescent signal for iLOV
appeared relatively faint. As discussed above, quenching
of iLOV fluorescence as a result of our cloning strategy is
unlikely, as expression of iLOV as a non-fusion product
gave similar results. Other factors, including the accu-
mulation and turnover of 2A in the cytoplasm or simply its
inherent fluorescent properties, may play a role. Numerous
GFP mutants have been engineered to optimize its use as a
molecular tool for research. These mutations improved the
spectral characteristics of GFP, changed the colour of the
emitted fluorescence and prevented dimerization (Shaner
et al., 2005). Therefore, like GFP, iLOV may benefit from
further optimization to enhance its spectral characteristics
when expressed in mammalian cells.
A number of recent studies have used replication-
competent viruses that express easily traceable reporter
genes to study the dynamics of viral infections.
Manicassamy et al. used a recombinant GFP-expressing
influenza virus to characterize viral dissemination in mice
and identified a diverse set of target host cells, including
macrophages, monocytes, neutrophils, respiratory dend-
ritic cells, B, NK, CD4 and CD8 cells; in addition, the GFP
influenza virus was used to investigate the action of
antiviral agents on these cell types (Manicassamy et al.,
2010). Sa´nchez-Puig and co-workers infected fresh pre-
parations of human peripheral blood leucocytes with
vaccinia virus recombinants expressing GFP and showed
a strong bias towards infection of monocytes, B lympho-
cytes and NK cells (Sa´nchez-Puig et al., 2004). iLOV-
FMDV offers a comparable tool for the characterization of
the FMDV life cycle. Its fluorescence and stability
properties make it suitable for in vitro live-cell experiments
investigating FMDV replication in cultured cells, in vivo
studies using the mouse as a model system to characterize
FMDV infection and ex vivo analysis of infected livestock
tissues to identify rare host cell types that facilitate viral
replication (Ferna´ndez et al., 1986; Reid et al., 2011;
Salguero et al., 2005). We have recently shown plasma-
cytoid dendritic cells (pDC) isolated from bovine mes-
enteric lymph nodes, pseudo-afferent lymph and blood
produce type I IFN in response to immune-complexed
FMDV. Future studies will utilize iLOV-FMDV to
investigate dissemination of FMDV in mice, as well as
the infection status of pDCs in vivo.
METHODS
Construction of viruses. Recombinant copy viruses, containing
either full-length Renilla luciferase ORF, full-length GFP ORF or
increasing portions of the GFP ORF (clones T2, T3, T4, T5, T6 or
T7), were constructed using reverse genetics and existing clones.
Briefly, an FMDV O1K/O UKG35 chimeric clone encoding the VP2,
VP3, VP1 and 2A products of FMDV UKG/35/2001 and the Lpro,
VP4, 2B, 2C, 3A, 3B, 3C and 3D products of FMDV O1K/O1Manisa
was used as the parental construct for all cloning in this study. This
recombinant copy virus has been previously described (Bøtner et
al., 2011; Seago et al., 2012). To facilitate cloning, a unique AvrII
restriction site was inserted into the genome of the O1K/O UKG35
chimera between DNA encoding the VP1 and 2A products. This
was done by performing two consecutive rounds of PCR
amplification using the QuikChange Lightning Mutagenesis kit
(Agilent Technologies) according to the manufacturer’s instruc-
tions. Respective GFP and Renilla luciferase inserts were PCR
amplified from existing clones and ligated into the AvrII restriction
site. The primers used for amplification of the Renilla luciferase and
GFP DNA inserts are listed in Table S1 (available in the online
version of this journal).
Preparation of infectious RNA, electroporation and transfec-
tion. RNA was transcribed from the infectious clones using the
MEGAscript T7 kit (Invitrogen). The infectious RNA was first
electroporated into BHK-21 cells using a Bio-Rad Gene PulsarTM
(two pulses at 0.75 kV and 25 mF). After 24 h, the cells were thawed
in their growth media and clarified by centrifugation, the supernatant
of which contained the initial virus stock (termed ‘passage 0’, P0). A
goat epithelium cell line expressing the principal FMDV receptor
(integrin avb6) was subsequently used to passage the tagged viruses
(P1) (Brehm et al., 2009). Cells were infected for 24 h between
passages. Electroporation of RNA was performed using the TransIT
mRNA Transfection kit (MoBiTec) according to the manufacturer’s
instructions.
Genome amplification and sequencing. Total RNA was extracted
using TRIzol reagent (Invitrogen) and the respective region of the
viral RNA genome was reverse transcribed and amplified by PCR
using a One-Step RT-PCR kit (Qiagen). Sequencing reactions were
then performed using an aliquot of the purified PCR product and the
BIG Dye Terminator v3.1 cycle sequencing kit (Applied Biosystems).
Western blot analysis. For Western blots, proteins were separated
by SDS-PAGE (12 % acrylamide) and then transferred to nitrocellu-
lose membranes (Hybond-C Extra, Amersham Biosciences).
Membranes were blocked with dried skimmed milk in PBS containing
0.1 % Tween 20. Primary monoclonal antibodies used were: 2C2
(mouse anti-FMDV 3A) (De Diego et al., 1997), mouse anti-c-tubulin
(Sigma-Aldrich), rabbit anti-GFP (Abcam) and rabbit anti-iLOV
(Chapman et al., 2008). Bound primary antibodies were detected by
horseradish peroxidase-conjugated anti-mouse or anti-rabbit anti-
bodies (Bio-Rad).
Immunofluorescence microscopy. Baby hamster kidney-21 cells
(BHK-21) cultured on glass coverslips were transfected with GFP-
FMDV transcripts using the TransIT mRNA transfection kit
(Cambridge Bioscience) according to the manufacturer’s instructions.
Goat epithelium cells (ZZ-R127) (Brehm et al., 2009) cultured on
glass coverslips were incubated with iLOV-FMDV. Uninfected cells
were included as a control. After 5 h, cells were fixed, permeabilized,
washed and blocked (0.5 % BSA in PBS). FMDV non-structural
protein 3A was labelled using monoclonal antibody 2C2 (De Diego
et al., 1997). Goat anti-mouse Molecular Probes Alexa-Fluor-
conjugated secondary antibodies (Invitrogen) were used, and nuclei
were stained with DAPI (Sigma-Aldrich). All data were sequentially
collected using a Leica SP2 scanning laser confocal microscope.
Plaque assay. Confluent monolayers of goat epithelium cells were
infected with serial dilutions of FMDV O1K/O UKG35 virus stocks,
overlaid with indubiose and incubated for 24 to 48 h at 37 uC. The
cells were then fixed and stained (4 % formaldehyde in PBS
containing methylene blue) before removal of the overlay (Jackson
et al., 2000).
Flow cytometry. Goat epithelium cells were either mock infected or
infected with iLOV-FMDV or parental-FMDV at an m.o.i. of 2. After
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4 h at 37 uC, the cells were fixed with 4 % paraformaldehyde, washed
in PBS and permeabilized in FACS diluent (0.2 % saponin/1 % BSA/
autoMACS Running buffer solution, Miltenyi Biotec, UK). All
subsequent steps were carried out in FACS diluent containing 5 %
normal goat serum (Sigma-Aldrich). Cells were blocked for 20 min at
room temperature then labelled with either anti-FMDV non-
structural protein 3A monoclonal antibody 2C2 (De Diego et al.,
1997), anti-FMDV capsid monoclonal antibody IB11 (IgG2a) (Juleff
et al., 2008) or isotype control monoclonal antibodies TRT1 (IgG1)
and TRT3 (IgG2a) (Cook et al., 1993). Antibodies were directly
conjugated with Zenon Alexa 647 fluorophores (Invitrogen). After
incubation for 30 min at room temperature, the cells were washed
and resuspended in PBS. Using a MACSQuant Analyser (Miltenyi
Biotec), single cell populations were gated based upon forward and
side scatter characteristics. The specific fluorescence of iLOV and Alexa-
Fluor 647 was measured upon excitation at 488 nm and 635 nm,
respectively. Data from 10 000 events were recorded, and the data was
analysed using FSC Express version 3 (De Nova Software, USA).
Live-cell imaging. Goat epithelium cells were grown on Lab-Tek
chambered coverglass slides (Nunc) and either mock infected or
infected with iLOV-FMDV or parental-FMDV at an m.o.i. of 2. After
2 h, cell culture medium was removed and replaced with Leibovitz’s
L-15 medium (Gibco). Images were acquired with a Leica SP2
confocal laser microscope with DMIRE2 inverted microscope stand in
a microscope chamber kept at 37 uC. The cells were viewed by
differential interference contrast optics, iLOV was excited at 488 nm,
and the emission fluorescence levels were detected by using a photo-
multiplicator between 500 and 570 nm. Time-lapse imaging of iLOV-
FMDV-infected cells was performed by acquiring images every
20 min over 5 h.
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